Jump to ContentJump to Main Navigation
The Nature and Dynamics of Organizational Capabilities$
Users without a subscription are not able to see the full content.

Giovanni Dosi, Richard R. Nelson, and Sidney Winter

Print publication date: 2001

Print ISBN-13: 9780199248544

Published to Oxford Scholarship Online: November 2003

DOI: 10.1093/0199248540.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 19 October 2021

Measuring Competence? Exploring Firm Effects in Drug Discovery

Measuring Competence? Exploring Firm Effects in Drug Discovery

(p.155) 6 Measuring Competence? Exploring Firm Effects in Drug Discovery
The Nature and Dynamics of Organizational Capabilities

Rebecca Henderson

Iain Cockburn

Oxford University Press

The chapter explores the role of ‘competence’ in pharmaceutical research. It provides support for the existence of sources of heterogeneity highlighted by the resource‐based view of the firm by showing that the large proportion of the variance in research productivity across firms could be attributed to firm‐specific effects. Drawing on detailed qualitative data about the history of research at each of the firm in the sample, a variety of measures of ‘competence’ was constructed. The result of the analysis suggests that ‘architectural competence’, as captured by indicators of the firm's ability to knowledge integrativity, is positively associated with research productivity. Besides that, it is shown that firms that maintain links to the wider scientific community through the use of publication in the open literature as a criterion of promotion, and firms that manage the allocation of key research resources through collaborative rather than dictatorial processes are significantly more productive in drug discovery.

Keywords:   collaboration, competencies, drug discovery, heterogeneity of firms, pharmaceutical industry, productivity, publication, research, scientific community

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .